Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00638885 · ClinicalTrials.gov registry record
Memory and the Hippocampus in Twins
A clinical trial, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- 142
- Enrollment target
NCT00638885: Completed study, sponsored by US Department of Veterans Affairs.
NCT00638885 is a clinical trial that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 142 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00638885 has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- 142 participants
- Enrollment target
Study Summary
The purpose of this project is to measure brain markers and cognitive factors in twins with a history of military service with and without PTSD, and to follow them over time and measure changes in brain function and cognitive variables.
Primary Outcome
Percent retention on the Wechsler Memory Scale - Logical
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2010-04 |
| Est. Completion | 2013-06 |
What the finished NCT00638885 record still lists
NCT00638885 is an observational study that tracks outcomes without assigning an intervention. The registered 142 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00638885 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00638885 about?
NCT00638885 is a clinical study titled "Memory and the Hippocampus in Twins". The purpose of this project is to measure brain markers and cognitive factors in twins with a history of military service with and without PTSD, and to follow them over time and measure changes in brain function and cognitive variables.
What is the current status of trial NCT00638885?
This trial is currently completed. The enrollment target is 142 participants. The study started on 2010-04. Estimated completion is 2013-06.
Who is sponsoring clinical trial NCT00638885?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03933631 · 142 participants · Phase 3
Pilocarpine Use After Kahook Goniotomy
- NCT04938349 · 142 participants · NA
Dual Task Perturbation Training for OAwMCI
- NCT06117254 · 142 participants · NA
Hearing Aids for Veterans With Functional Hearing Difficulties
- NCT06463665 · 142 participants · Phase 2
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia